Advicenne is a startup based in France, 1 tracked investor.
Based in France, Advicenne is a startup founded in 2009. Brouky records 1 investor associated with the company.
Advicenne is a pharmaceutical company that develops and commercializes innovative treatments for rare kidney diseases, with a focus on pediatric populations. Its lead product, Sibnayal, is approved for distal renal tubular acidosis (dRTA).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.